[Translation] A single-center, randomized, open-label, single-dose, three-sequence, three-cycle, three-crossover clinical trial to evaluate the relative bioavailability and food effects of SYHA1813 oral solution in healthy participants
本研究的主要目的为评估中国健康参与者在空腹状态下单次口服SYHA1813口服液新制剂的相对生物利用度和评估食物对SYHA1813口服液新制剂药代动力学特征的影响;
次要目的为评价中国健康参与者单次口服SYHA1813口服液的安全性和耐受性。
[Translation] The main purpose of this study is to evaluate the relative bioavailability of the new formulation of SYHA1813 oral liquid in Chinese healthy participants in a single oral administration in the fasting state and to evaluate the impact of food on the pharmacokinetic characteristics of the new formulation of SYHA1813 oral liquid;
The secondary objective is to evaluate the safety and tolerability of a single oral dose of SYHA1813 oral solution in healthy Chinese participants.